Tracks and optimizes radiation exposure using reference levels and ALARA principles. Use when monitoring radiation dose, optimizing CT protocols, or documenting dose reduction efforts.
Tracks and optimizes radiation exposure using reference levels and ALARA principles.
Medical imaging is the largest source of man-made radiation exposure, with the average annual per-capita effective dose from medical imaging in the U.S. exceeding 3 mSv. CT alone accounts for approximately 75% of medical radiation dose despite representing only 15% of imaging volume. The linear no-threshold (LNT) model, endorsed by the NCRP and ICRP, assumes any radiation dose carries some cancer risk, making dose optimization a professional and regulatory obligation.
The ALARA principle (As Low As Reasonably Achievable) is mandated by the NRC, state radiation protection agencies, and ACR accreditation standards. The ACR Dose Index Registry (DIR) provides national benchmarks (diagnostic reference levels, or DRLs) against which facilities compare their dose performance. CMS Conditions of Participation require dose documentation, and The Joint Commission has recognized diagnostic radiation as a sentinel event trigger when doses exceed expected thresholds. This skill provides the systematic framework for dose monitoring, optimization, documentation, and reporting required by these standards.
| Metric | Definition | Clinical Use |
|---|---|---|
| CTDIvol (mGy) | Average dose per slice, normalized by phantom size | Compare protocols; scanner output metric |
| DLP (mGy·cm) | CTDIvol × scan length | Total dose for the exam; basis for effective dose estimation |
| SSDE (mGy) | Size-specific dose estimate — CTDIvol adjusted for patient size | Most accurate individual patient dose; accounts for body habitus |
| Effective dose (mSv) | DLP × conversion factor (k) | Approximates whole-body stochastic risk; used for patient counseling |
| Body Region | k Factor (mSv / mGy·cm) |
|---|---|
| Head | 0.0021 |
| Neck | 0.0059 |
| Chest | 0.014 |
| Abdomen | 0.015 |
| Pelvis | 0.015 |
| Metric | Definition |
|---|---|
| DAP (Gy·cm²) | Dose-area product: total beam output × field area |
| Cumulative air kerma (mGy) | Dose at the interventional reference point (IRP) |
| Fluoroscopy time (min) | Total beam-on time; correlate with DAP |
| Skin dose threshold | >2 Gy: possible skin erythema; >5 Gy: likely skin injury |
| CT Exam | 50th Percentile CTDIvol (mGy) | 75th Percentile (DRL) CTDIvol (mGy) | 50th Percentile DLP (mGy·cm) | 75th DRL DLP (mGy·cm) |
|---|---|---|---|---|
| CT Head | 51 | 60 | 860 | 1050 |
| CT Chest | 8 | 12 | 310 | 470 |
| CT Abdomen/Pelvis | 11 | 15 | 510 | 720 |
| CT Chest/Abdomen/Pelvis | 10 | 14 | 650 | 950 |
| CT Lumbar Spine | 20 | 30 | 530 | 780 |
If institutional dose exceeds the 75th percentile DRL:
| Technique | Expected Reduction | Considerations |
|---|---|---|
| Reduce kVp (120 → 100 or 80) | 30–50% dose reduction | Effective for thin patients and CTA; increased noise in obese patients |
| Automatic exposure control (AEC) | 20–40% reduction | Must be properly calibrated; set appropriate noise index |
| Iterative reconstruction | 25–50% reduction vs. FBP | Allows lower mAs without increased noise; model-based IR (MBIR) most effective |
| Reduce scan length | Proportional to length reduction | Do not extend beyond anatomy of interest; avoid "scout and scan" mismatch |
| Reduce number of phases | Proportional to phases eliminated | Single-phase CT often sufficient; eliminate non-contributory pre-contrast or delayed phases |
| Increase pitch | Proportional to pitch increase | Faster scan; may reduce spatial resolution |
| Organ-based tube current modulation | 20–30% reduction to specific organs | Protects breasts, thyroid, lens — available on newer scanners |
| Shielding | Variable | Bismuth shields for breast/thyroid — controversial with AEC; verify no artifact |
| Principle | Implementation |
|---|---|
| Image Gently campaign | Size-based protocols mandatory; never use adult parameters |
| Weight-based kVp | <50 kg: 80 kVp; 50–80 kg: 100 kVp; >80 kg: 120 kVp |
| Weight-based mAs | Per scanner-specific pediatric protocol table |
| Limit phases | Single-phase CT whenever possible; avoid multiphase |
| Alternative modality | Ultrasound or MRI preferred when diagnostically equivalent |
Every CT report should include (per ACR standards):
| Trigger | Action |
|---|---|
| Single exam exceeds institutional DRL by >50% | Real-time alert to supervising radiologist; review justification |
| Single exam exceeds DRL by >100% | Immediate protocol review; document rationale (e.g., large body habitus, repeat acquisition due to motion) |
| Fluoroscopy cumulative air kerma >2 Gy | Alert proceduralist; document skin dose and patient notification |
| Fluoroscopy cumulative air kerma >5 Gy | Patient follow-up required; document in medical record; notify referring provider |
| Pediatric dose exceeds age-appropriate DRL | Mandatory protocol review within 24 hours |
| Requirement | Authority | Detail |
|---|---|---|
| Dose documentation in report | ACR, CMS | CTDIvol and DLP per series/study |
| Dose registry participation | ACR DIR | Quarterly or continuous data submission |
| Significant dose event reporting | State radiation protection | Varies by state; typically triggered by high-dose alerts |
| Sentinel event reporting | Joint Commission | If dose causes patient harm |
| Equipment quality control | State/FDA | Annual physicist survey; dose output verification |